πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 11 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12377151

Immobilized endoglycosidase fusion protein and use thereof

GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. Β· Granted Tue Aug 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12318457

Oligosaccharide linker, linker-payload comprising the same and glycan chain-remodeled anti

GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. Β· Granted Tue Jun 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11999748

Exatecan derivatives, linker-payloads, and conjugates and thereof

GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. Β· Granted Tue Jun 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11911435

Stable antibody-drug conjugate, preparation method therefor, and use thereof

GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. Β· Granted Tue Feb 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11911434

Stable antibody-drug conjugate, preparation method therefor, and use thereof

GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. Β· Granted Tue Feb 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11834688

Ligase fusion proteins and application thereof

GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. Β· Granted Tue Dec 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11826432

Linkers, conjugates and applications thereof

GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. Β· Granted Tue Nov 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11814394

Exatecan derivatives, linker-payloads, and conjugates and thereof

GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. Β· Granted Tue Nov 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11717576

Antibody-immune agonist conjugate and applications thereof

GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. Β· Granted Tue Aug 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11453870

Ligase fusion proteins and application thereof

GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. Β· Granted Tue Sep 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11040084

Stable antibody-drug conjugate, preparation method therefor, and use thereof

GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. Β· Granted Tue Jun 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted